Officielt resumé · English
Hvad indkøbes?
Biomedicum Imaging Unit In Vivo Imaging (BIU-IVI) is an open-access core service research infrastructure at the Faculty of Medicine, University of Helsinki, part of the Helsinki In Vivo Animal Imaging Platform (HAIP) of Helsinki Institute of Life Science (HiLife). BIU-IVI provides unique multimodal live animal imaging equipment and services for pre-clinical biomedical research. BIU-IVI acquired a modular imaging system for rodent positron emission tomography (PET) and X-ray computed tomography (CT) of rodents in 2022 from Molecubes, currently part of Bruker. With this system, the PET signal from radiolabeled tracers can be automatically co-registered with a CT image as an anatomical reference, with easy transfer of experimental animals between the two imaging modules.…
Vejledende maskinoversættelse. Det officielle resumé er fortsat gældende.
Officielt resumé · English
Biomedicum Imaging Unit In Vivo Imaging (BIU-IVI) is an open-access core service research infrastructure at the Faculty of Medicine, University of Helsinki, part of the Helsinki In Vivo Animal Imaging Platform (HAIP) of Helsinki Institute of Life Science (HiLife). BIU-IVI provides unique multimodal live animal imaging equipment and services for pre-clinical biomedical research. BIU-IVI acquired a modular imaging system for rodent positron emission tomography (PET) and X-ray computed tomography (CT) of rodents in 2022 from Molecubes, currently part of Bruker. With this system, the PET signal from radiolabeled tracers can be automatically co-registered with a CT image as an anatomical reference, with easy transfer of experimental animals between the two imaging modules.…
Meddelelseshistorik
Udbudsforløb
Følg de vigtigste faser og opdateringer i dette udbud.
Data er omstruktureret for at være lettere at læse. Den officielle meddelelse og udbudsdokumenterne er altid gældende.
Kilde og pålidelighed
TED · 474632-2026. Kontrolleret 23. aug. 2026 15.05.
Data er omstruktureret for at være lettere at læse. Den officielle meddelelse og udbudsdokumenterne er altid gældende.